Seutic Pharma Private Limited, a active private limited company, was established on 23 July 2014 in Hyderabad, Telangana, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24297TG2014PTC095025. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹6.00 Cr and a paid-up capital of ₹6.00 Cr.
It upholds a compliant status. Employing 58 professional, Its leadership includes Venkata Siva Vara Prasad Valivarthi (Director), Padma Valivarthi (Director), Punukollu Kodanda Rambabu (Additional Director). It holds ₹63.60 Cr open charges and ₹4.00 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 2Nd Floor , D-73/P , D-74/P ,Quthbullapur , Apiidc Phase-1 , Jeedimetla, Hyderabad, Telangana, 500055.
U24297TG2014PTC095025
095025
23 July 2014
₹6.00 Cr
₹6.00 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Seutic Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Venkata Siva Vara Prasad Valivarthi | Director | 23 Jul 2014 | Current |
| Padma Valivarthi | Director | 23 Jul 2014 | Current |
| Punukollu Kodanda Rambabu | Additional Director | 27 Jun 2025 | Current |
| Jayaram Gunturu | Additional Director | 27 Jun 2025 | Current |
| Sudhakar Kalle | Additional Director | 22 May 2025 | Current |
| Prithvi Prasad Motaparti | Additional Director | 11 Jul 2025 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Seutic Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 83.76% increase. The company also saw a substantial improvement in profitability, with a 133.89% increase in profit. The company's net worth Soared by an impressive increase of 24.73%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Seutic Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹636,006,949.00
₹4,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Sep 2025 | Others | ₹4.03 M | Open |
| 07 Jan 2025 | Others | ₹5.00 Cr | Open |
| 30 Sep 2022 | Others | ₹7.26 M | Open |
| 30 Dec 2021 | Others | ₹1.00 Cr | Open |
| 30 Sep 2021 | Others | ₹28.18 Cr | Open |
Explore comprehensive loan charge details -
Seutic Pharma has a workforce of 58 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Seutic Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Seutic Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others amounted to Rs. 0.40 Cr with Charge ID 101159444 was registered on 24 Sep 2025. was recorded as a recent event.
Prithvi Prasad Motaparti was appointed as a Additional Director was appointed as a Additional Director on 11 Jul 2025 & has been associated with this company since 4 months 23 days . was recorded as a recent event.
Punukollu Kodanda Rambabu was appointed as a Additional Director was appointed as a Additional Director on 27 Jun 2025 & has been associated with this company since 5 months 6 days . was recorded as a recent event.
Jayaram Gunturu was appointed as a Additional Director was appointed as a Additional Director on 27 Jun 2025 & has been associated with this company since 5 months 6 days . was recorded as a recent event.
Sudhakar Kalle was appointed as a Additional Director was appointed as a Additional Director on 22 May 2025 & has been associated with this company since 6 months 12 days . was recorded as a recent event.
The activity A charge with Others amounted to Rs. 5.00 Cr with Charge ID 101026748 was registered on 07 Jan 2025. was completed.
The CIN of Seutic Pharma Private Limited is U24297TG2014PTC095025.
Seutic Pharma Private Limited is headquartered at 2Nd Floor , D-73/P , D-74/P ,Quthbullapur , Apiidc Phase-1 , Jeedimetla, Hyderabad, Telangana, 500055.
Seutic Pharma Private Limited was incorporated on 23 July 2014.
The current directors of Seutic Pharma Private Limited are
The primary industry of Seutic Pharma Private Limited is Manufacturing.
Seutic Pharma Private Limited is unlisted.
The authorized capital of Seutic Pharma Private Limited is ₹6.00 Cr, and the paid-up capital is ₹6.00 Cr.
The compliance status of Seutic Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX